XML 209 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Common Class A
Previously Reported [Member]
Common Stock
Common Class A
Revision of Prior Period, Elimination of Historical Equity [Member]
Common Stock
Common Class A
Revision of Prior Period, Retroactive Application of Recapitalization [Member]
Common Stock
Common Class A
Additional Paid - In Capital
Previously Reported [Member]
Additional Paid - In Capital
Retained Earnings (Deficit)
Previously Reported [Member]
Retained Earnings (Deficit)
Previously Reported [Member]
Total
Beginning Balance at Dec. 31, 2021         $ 2,010 $ 2,010 $ 2,427 $ 2,427 $ 4,437 $ 4,437
Beginning Balance (in shares) at Dec. 31, 2021 514,946 (514,946) 5,292,384 5,292,384            
Net (loss)               (13,290)   (13,290)
Share-based compensation           644       644
Ending Balance at Dec. 31, 2022           2,654   (10,863)   (8,209)
Ending Balance (in shares) at Dec. 31, 2022       514,946            
Net (loss)               (2,907)   (2,907)
Share-based compensation           87       87
Ending Balance at Mar. 31, 2023           2,741   (13,770)   (11,029)
Ending Balance (in shares) at Mar. 31, 2023       514,946            
Beginning Balance at Dec. 31, 2022           2,654   (10,863)   (8,209)
Beginning Balance (in shares) at Dec. 31, 2022       514,946            
Net (loss)               (22,268)   (22,268)
Conversion of stockholder promissory note           18,501       18,501
Conversion of stockholder promissory note (in shares)       1,459,700            
Conversion of convertible notes           2,054       2,054
Conversion of convertible notes (in shares)       550,486            
Financing transaction shares           4,641       4,641
Financing transaction shares (in shares)       680,500            
Issuance of common stock (in shares)       282,074            
Merger recapitalization (Note 3)       $ 1   (1,454)       (1,453)
Merger recapitalization (Note 3) (in shares)       3,691,679            
Deferred transaction costs           (7,595)       (7,595)
Share-based compensation           14,061       14,061
Ending Balance at Dec. 31, 2023       $ 1   32,862   (33,131)   (268)
Ending Balance (in shares) at Dec. 31, 2023       11,956,823            
Net (loss)               (3,922)   (3,922)
Conversion of stockholder promissory note           200       200
Conversion of stockholder promissory note (in shares)       41,016            
Conversion of convertible notes           4,475       4,475
Conversion of convertible notes (in shares)       540,897            
Financing transaction shares           876       876
Financing transaction shares (in shares)       387,560            
Ending Balance at Mar. 31, 2024       $ 1   $ 38,413   $ (37,053)   $ 1,361
Ending Balance (in shares) at Mar. 31, 2024       12,926,296